Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats
- 15 January 2011
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 650 (2-3) , 556-562
- https://doi.org/10.1016/j.ejphar.2010.10.047
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Diet‐induced obesity in Sprague–Dawley rats causes microvascular and neural dysfunctionDiabetes/Metabolism Research and Reviews, 2010
- Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failureRenal Failure, 2010
- Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic eventsAmerican Heart Journal, 2009
- Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunctionDiabetes, Obesity and Metabolism, 2009
- Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688Experimental Diabetes Research, 2009
- Epidermal nerve fiber quantification in the assessment of diabetic neuropathyActa Histochemica, 2008
- C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factorThe International Journal of Biochemistry & Cell Biology, 2004
- Neutral endopeptidase expression in mesangial cellsJournal of the Renin-Angiotensin-Aldosterone System, 2003
- The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptidesBritish Journal of Clinical Pharmacology, 1997
- Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase in Rats with HypertensionJournal of Cardiovascular Pharmacology, 1995